Ocrelizumab-Induced Severe Colitis

Joint Authors

Lee, Hsing Hwa
Sritharan, Naveen
Bermingham, Daniel
Strey, Gabriela

Source

Case Reports in Gastrointestinal Medicine

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-4, 4 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-12-07

Country of Publication

Egypt

No. of Pages

4

Main Subjects

Diseases

Abstract EN

We report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy.

Histology of the colectomy was consistent with medication-induced colitis.

American Psychological Association (APA)

Lee, Hsing Hwa& Sritharan, Naveen& Bermingham, Daniel& Strey, Gabriela. 2020. Ocrelizumab-Induced Severe Colitis. Case Reports in Gastrointestinal Medicine،Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1147527

Modern Language Association (MLA)

Lee, Hsing Hwa…[et al.]. Ocrelizumab-Induced Severe Colitis. Case Reports in Gastrointestinal Medicine No. 2020 (2020), pp.1-4.
https://search.emarefa.net/detail/BIM-1147527

American Medical Association (AMA)

Lee, Hsing Hwa& Sritharan, Naveen& Bermingham, Daniel& Strey, Gabriela. Ocrelizumab-Induced Severe Colitis. Case Reports in Gastrointestinal Medicine. 2020. Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1147527

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1147527